You can’t argue against facts.
Highlighting facts and missteps is not disparaging, it’s the truth. Just one single example:
I wonder out loud if any people felt misled about the conjunctivitis dream.
2013 CEO via ASX release:“SPL7013 has the potential to be a first-in-class anti-viral agent for viral conjunctivitis (VC)” ~ a direct quote from CEO !!
”A global market of US$700m exists for effective VC treatments” ~ a direct quote from CEO !!!
”Based on feedback from potential partners and clinicians this opportunity is being advanced..” - a direct quote from CEO !!
2014:
2015:
2016:
2017:
2018:
2019:
2020:
2021:
At the 2021 Starpharma AGM during Q&A with the CEO, shareholders were made aware that SPL7013 and viral-conjunctivitis was now not a priority.
This is truly shameful. But this is quite typical of what Starpharma do, and continue to do. Hello … the Indian distribution deal which supposedly was well advanced in partnering discussions for Viraleze. Still waiting…
DYOR
- Forums
- ASX - By Stock
- SPL
- Watch out disparaging and defamatory posters
Watch out disparaging and defamatory posters
-
- There are more pages in this discussion • 11 more messages in this thread...
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.6¢ |
Change
0.002(1.60%) |
Mkt cap ! $39.38M |
Open | High | Low | Value | Volume |
9.4¢ | 9.6¢ | 9.4¢ | $32.09K | 339.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 3699 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.8¢ | 65000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 3699 | 0.095 |
2 | 36266 | 0.094 |
2 | 260000 | 0.093 |
1 | 60000 | 0.092 |
1 | 6400 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.098 | 65000 | 1 |
0.099 | 56700 | 2 |
0.100 | 111205 | 3 |
0.105 | 66531 | 4 |
0.110 | 43099 | 6 |
Last trade - 13.54pm 06/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |